~~<i id='FF98E57DB5'><strike id='FF98E57DB5'><tt id='FF98E57DB5'><pre id='FF98E57DB5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

explore

author：Wikipedia 2025-08-12 11:29:16 - browse：11

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： As billionaires fund anti

focus

hotspot

focus

hotspot

entertainment

hotspot

KentNishimura/GettyImagesYou’rereadingthewebversionofHealthCareInc.,STAT’sweeklynewsletterfollowingt

WSS

What Mike Pence has said that could be used in a Donald Trump trial

PBM executives asked to testify by House panel

Verily hires former Apple Health leader as chief scientific officer

Empower primary care with adequate payments and technology

Brain MRIs reveal impact of 'toxic stress' on Black children

Influencer to be charged after chaos erupts in New York City's Union Square

hotspot

explore

focus

Hepatitis C has a cure — but many Americans still lack access to it

Crowdfunding for medical bills sidesteps core problem, author says

Sports medicine is finally prioritizing gender equality

As health system earnings go up, health insurance stocks go down

Jerome Adams on the need for new antivirals for Covid

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

In Memoriam: Notable people who died in 2023

Is it ever OK for doctors to lie to their patients?

Affirmative action in medical school literally saved lives

Chemotherapy before breast cancer surgery might fuel metastasis

hotspot

Crowdfunding for medical bills sidesteps core problem, author says

Is it ever OK for doctors to lie to their patients?

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

Chemotherapy before breast cancer surgery might fuel metastasis

Gilgo Beach: Police identify another victim in serial killing investigation

AltruBio raises $225 million to develop ulcerative colitis drug

focus

hotspot

entertainment

hotspot